Treatment option following papillectomy
Prospective, multi-center study has shown1
- Camus, Efficacy and safety of endobiliary radiofrequency ablation for the eradication of residual neoplasia after endoscopic papillectomy: a multicenter prospective study, GIE Journal ,vol 88, No3, 2018
- Studies are limited due to small patient sample sizes and uncontrolled study designs
- RFA should be used selectively in patients for whom treatment of an intraductal lesion is appropriate, other endoscopic modalities are likely to be insufficient, and the main treatment alternative is pancreaticoduodenectomy."
- Close monitoring of these patients remains warranted considering the risks of local recurrence and progression
All trademarks are the property of their respective owners.
CAUTION: The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings and instructions for use can be found in the product labelling supplied with each device.
Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. This material not intended for use in France.
Product available in the European Economic Area (EEA) only. Please check availability with your local sales representative or customer service.